
Sign up to save your podcasts
Or


Sergei is the founder and CEO of 100XBIO, a Boston-based startup automating cell biology. An immunologist with 20 years of R&D experience, he previously led preclinical research for oncology and mRNA vaccine projects. He believes we cannot accelerate biotech while most lab experiments are still run manually. Sergei is now building a "one-click" benchtop instrument to make life-saving research 10x more efficient and research infrastructure AI-ready. Automating complex workflows is the only path to truly AI-driven biology labs.
By Megan DriscollSergei is the founder and CEO of 100XBIO, a Boston-based startup automating cell biology. An immunologist with 20 years of R&D experience, he previously led preclinical research for oncology and mRNA vaccine projects. He believes we cannot accelerate biotech while most lab experiments are still run manually. Sergei is now building a "one-click" benchtop instrument to make life-saving research 10x more efficient and research infrastructure AI-ready. Automating complex workflows is the only path to truly AI-driven biology labs.